Granules India's Q3 FY 2025-26 Quarterly Results
- 24 Jan 2026
Result Summary
- Granules India Ltd reported a 6.8% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Dec (Q3 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a growth of 21.1%.
- Its expenses for the quarter were up by 5.5% QoQ and 19.3% YoY.
- The net profit increased 15.0% QoQ and increased 27.7% YoY.
- The earnings per share (EPS) of Granules India Ltd stood at 6.19 during Q3 FY 2025-26.
Financial Statments for Q3 FY 2025-26
Total Income | 1384.30 | 1295.84 | 1143.37 | 6.8% | 21.1% |
Total Expenses | 1182.06 | 1119.97 | 990.58 | 5.5% | 19.3% |
Profit Before Tax | 202.23 | 175.86 | 152.79 | 15.0% | 32.4% |
Tax | 52.02 | 45.26 | 35.19 | 14.9% | 47.8% |
Profit After Tax | 150.21 | 130.61 | 117.60 | 15.0% | 27.7% |
Earnings Per Share | 6.19 | 5.38 | 4.85 | 15.1% | 27.6% |
Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results
Company Overview
Granules India Ltd is a pharmaceutical company that operates in the healthcare and pharmaceutical industry. It is primarily engaged in the manufacturing and selling of pharmaceutical products, including Active Pharmaceutical Ingredients (APIs), Pharmaceutical Formulation Intermediates (PFIs), and Finished Dosages. The company serves a diverse range of markets, offering a broad spectrum of products that leverage its manufacturing capabilities. As a key player in the pharmaceutical industry, Granules India Ltd is involved in both domestic and international markets. However, specific recent developments or strategic initiatives undertaken by the company are not available in the provided data.
Revenue
For the third quarter of the fiscal year 2026 (Q3FY26), Granules India Ltd reported a total income of ₹1384.30 crores. This represents a quarter-over-quarter (QoQ) increase of 6.8% from ₹1295.84 crores in Q2FY26 and a year-over-year (YoY) increase of 21.1% from ₹1143.37 crores in Q3FY25. The consistent growth in total income over these periods suggests an expansion in the company's revenue-generating activities. The increase in total income indicates that the company has successfully grown its revenue over the past year, maintaining a positive trajectory in its financial performance.
Profitability
Granules India Ltd's profitability for Q3FY26 can be evaluated through its profit before tax (PBT), which stood at ₹202.23 crores. This reflects a 15.0% QoQ growth from ₹175.86 crores in Q2FY26 and a 32.4% YoY growth from ₹152.79 crores in Q3FY25. The profit after tax (PAT) for Q3FY26 was reported at ₹150.21 crores, marking a 15.0% QoQ increase from ₹130.61 crores in Q2FY26 and a 27.7% YoY increase from ₹117.60 crores in Q3FY25. The tax expense for Q3FY26 was ₹52.02 crores, showing a 14.9% QoQ increase from ₹45.26 crores in Q2FY26 and a 47.8% YoY increase from ₹35.19 crores in Q3FY25. The growth in profitability metrics indicates that the company has been able to enhance its bottom line over the past year.
Operating Metrics
The operating metrics for Granules India Ltd include the total expenses, which were ₹1182.06 crores for Q3FY26. This represents a 5.5% QoQ increase from ₹1119.97 crores in Q2FY26 and a 19.3% YoY increase from ₹990.58 crores in Q3FY25. The earnings per share (EPS) for Q3FY26 was noted at ₹6.19, indicating a 15.1% QoQ growth from ₹5.38 in Q2FY26 and a 27.6% YoY growth from ₹4.85 in Q3FY25. The upward trend in EPS demonstrates an improvement in shareholder value over time. The increase in total expenses, although significant, has been effectively managed to ensure profitability growth, as evidenced by the increase in both PBT and PAT.